Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review

ABSTRACT:

Introduction

Reports of unexpected side effects have accompanied the vaccination of larger proportions of the population against coronavirus disease 2019 (COVID-19), including a few cases of inflammatory myopathy (IM). In a bid to improve understanding of the clinical course of vaccine complications, a systematic review of reported cases of IM following COVID-19 vaccination has been conducted.

Methods

The PRISMA guideline 2020 was followed. Two independent investigators systematically searched PubMed and Embase to identify relevant studies published up to July 2022, using the following keywords: COVID-19 Vaccine, inflammatory myositis. The Joanna Briggs Institute critical appraisal tools were used for the risk of bias.

Results

A total of 24 articles presenting cl

SUBMITTER: Ding Y 

PROVIDER: S-EPMC9634642 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature